The GI therapeutics and diagnostics market, a major player in healthcare, has seen remarkable advancements in biologics. Despite progress, unmet needs in conditions like GI cancer and inflammatory bowel disease signal opportunities for innovation and growth. BOSTON , April 15, 2024…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.